Pacer Advisors, Inc. Abb Vie Inc. Transaction History

Pacer Advisors, Inc.

$38.6 Billion
Q1 2024

A detailed history of Pacer Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 396,382 shares of ABBV stock, worth $63.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

396,382

Previous 2,852,749 86.11%

Holding current value

$63.9 Million

Previous $442 Million 83.67%

% of portfolio

0.19%

Previous 1.4%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $393 Million - $447 Million	-2,456,367 Reduced 86.11%	396,382 $72.2 Million
Q4 2023 Jan 16, 2024	BUY	$137.6 - $154.97 $52.6 Million - $59.3 Million	382,406 Added 15.48%	2,852,749 $442 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $34.2 Million - $39.6 Million	256,318 Added 11.58%	2,470,343 $368 Million
Q2 2023 Jul 12, 2023	BUY	$132.51 - $164.9 $48.2 Million - $60 Million	363,583 Added 19.65%	2,214,025 $298 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $254 Million - $293 Million	1,758,035 Added 1902.49%	1,850,442 $295 Million

Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $155 Million - $186 Million	-1,118,399 Reduced 92.37%	92,407 $14.9 Million
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $143 Million - $165 Million	1,069,033 Added 754.05%	1,210,806 $163 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $1.42 Million - $1.8 Million	10,316 Added 7.85%	141,773 $21.7 Million
Q1 2022 Apr 05, 2022	SELL	$131.98 - $163.75 $28.7 Million - $35.6 Million	-217,311 Reduced 62.31%	131,457 $21.3 Million
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $6.57 Million - $8.31 Million	61,151 Added 21.26%	348,768 $47.2 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $16.6 Million - $18.9 Million	156,466 Added 119.3%	287,617 $31 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $1.17 Million - $1.3 Million	11,097 Added 9.24%	131,151 $14.8 Million
Q1 2021 Apr 05, 2021	SELL	$102.3 - $112.62 $840,189 - $924,948	-8,213 Reduced 6.4%	120,054 $13 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $2.59 Million - $3.5 Million	-32,213 Reduced 20.07%	128,267 $13.7 Million
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $5.94 Million - $6.97 Million	-69,135 Reduced 30.11%	160,480 $14.1 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $10.6 Million - $14.2 Million	144,244 Added 168.96%	229,615 $22.5 Million
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $2.53 Million - $3.84 Million	39,288 Added 85.25%	85,371 $7.12 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $17.3 Million - $21.6 Million	-239,765 Reduced 83.88%	46,083 $4.08 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $1.61 Million - $1.93 Million	25,514 Added 9.8%	285,848 $21.6 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $1.5 Million - $1.91 Million	22,778 Added 9.59%	260,334 $18.9 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $12 Million - $14.1 Million	155,097 Added 188.09%	237,556 $19.1 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $5.64 Million - $6.96 Million	-72,445 Reduced 46.77%	82,459 $7.6 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $4.33 Million - $4.81 Million	48,712 Added 45.87%	154,904 $14.7 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $4.04 Million - $4.78 Million	45,016 Added 73.58%	106,192 $9.84 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $508,355 - $680,735	5,525 Added 9.93%	61,176 $5.79 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $833,445 - $913,942	-9,306 Reduced 14.33%	55,651 $5.38 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $4.54 Million - $5.8 Million	64,957	64,957 $5.77 Million

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Abb Vie Inc. Transaction History